Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Advance contracts needed for pandemic antiviral supply

By Newsteam

Contracts for supply of antivirals by community pharmacies during an influenza pandemic should be agreed and drawn up in advance, the All Party Parliamentary Group on Primary Care and Public Health has recommended in its report on the swine flu pandemic (PDF 370K) published this week (10 March 2010).

“Pharmacists were disappointed that clear protocols developed before the pandemic appeared to be ignored by primary care trusts when the pandemic arrived and suggest a national service specification and standardised fee framework for the basic supply of antivirals is set up ahead of the next pandemic,” the report says.

The group also heard that pharmacy involvement in activities during the pandemic was patchy and recommend that PCTs and pharmacy bodies encourage engagement.

Oral and written evidence was provided by the Pharmaceutical Services Negotiating Committee, the Health Protection Agency and the Royal College of General Practitioners.

Citation: The Pharmaceutical Journal URI: 11001207

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.